Hvis der samtidig gives antiviral- behandling pga. hepatitis B eller C henvises til de pågældende produktresuméer for disse lægemidler.
In the case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products.